Carbon-11 labelling of MADAM in two different positions: a highly selective PET radioligand for the serotonin transporter

被引:66
|
作者
Tarkiainen, J
Vercouille, J
Emond, P
Sandell, J
Hiltunen, J
Frangin, Y
Guilloteau, D
Halldin, C [1 ]
机构
[1] Karolinska Inst, Karolinska Hosp, Dept Clin Neurosci, Psychiat Sect, S-17176 Stockholm, Sweden
[2] Univ Tours, INSERM, U316, F-37200 Tours, France
[3] MAP Med Technol Oy, FIN-00251 Helsinki, Finland
关键词
C-11]MADAM; serotonin transporter; 5-HTT; carbon-11; PET;
D O I
10.1002/jlcr.523
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Imaging by scintigraphy the serotonin transporter (5-HTT) in the living human brain would be of great value in research on the pathophysiology and treatment of neuropsychiatric disorders such as depression. For that reason, and in order to obtain a selective radiotracer applicable to PET, we report here the carbon-11 labelling of a selective 5-HTT radioligand: N, N-dimethyl-2-(2-amino-4-methylphenylthio)benzylamine or MADAM in two different positions: [p-C-11-methyl]MADAM and [N-C-11-methyl]MADAM. The synthesis of Bu3Sn-ADAM and N-dimethyl-MADAM is described. [p-C-11-methyl]MADAM was obtained by a Stille coupling reaction between Bu3Sn-ADAM and [C-11]methyl iodide using palladium (0) as a catalyst without (Ia) or with cop-per chloride as a co-catalyst (Ib). [N-C-11-methyl]MADAM was obtained by an N-methylation reaction between N-demethyl-MADAM and [C-11]methyl iodide (II). The carbon-11 incorporation yield in [p-C-11-methyl]MADAM was 10-30% (Ia and Ib) and in [N-C-11-methyl]MADAM was 75-80% (II). The final product in each case was obtained in 30 min total synthesis time, including HPLC purification and with > 99% radiochemical purity. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:1013 / 1023
页数:11
相关论文
共 50 条
  • [31] Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [11C]MADAM PET study
    Finnema, Sjoerd J.
    Halldin, Christer
    Bang-Andersen, Benny
    Bundgaard, Christoffer
    Farde, Lars
    PSYCHOPHARMACOLOGY, 2015, 232 (21-22) : 4159 - 4167
  • [32] Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [11C]MADAM PET study
    Sjoerd J. Finnema
    Christer Halldin
    Benny Bang-Andersen
    Christoffer Bundgaard
    Lars Farde
    Psychopharmacology, 2015, 232 : 4159 - 4167
  • [33] Radiolabelling with carbon-11 of sulfasalazine for PET imaging of cystine transporter Xc- involved in the radioresistance of glioblastoma
    Morloz, M.
    Ibazizene, M.
    Perrio, C.
    Barre, L.
    Gourand, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S261 - S262
  • [34] Serotonin transporter binding in unmedicated bipolar disorder subjects using [carbon-11] DASB and positron emission tomography
    Cannon, DM
    Ichise, M
    Fromm, S
    Nugent, AC
    Rollis, D
    Gandhi, SK
    Drevets, WC
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S101 - S102
  • [35] Carbon-11 labelling of S38419, a novel alpha-4-beta-2-selective ligand for PET imaging of nicotinic acetylcholine receptors
    Dolle, Frederic
    Demphel, Stephane
    Saba, Wadad
    Schoellhorn-Peyronneau, Marie-Anne
    Charton, Yves
    Goldstein, Solo
    Deverre, Jean-Robert
    Bottlaender, Michel
    Lestage, Pierre
    Valette, Heric
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S272 - S272
  • [36] Development of carbon-11 labeled acryl amides for selective PET imaging of active tissue transglutaminase
    van der Wildt, Berend
    Wilhelmus, Micha M. M.
    Bijkerk, Jonne
    Haveman, Lizeth Y. F.
    Kooijman, Esther J. M.
    Schuit, Robert C.
    Bol, John G. J. M.
    Jongenelen, Cornelis A. M.
    Lammertsma, Adriaan A.
    Drukarch, Benjamin
    Windhorst, Albert D.
    NUCLEAR MEDICINE AND BIOLOGY, 2016, 43 (04) : 232 - 242
  • [37] Development of a carbon-11 PET pro-radiotracer for imaging the astroglial excitatory amino acid transporter 2
    Fontana, Igor
    Zimmer, Eduardo
    Souza, Diogo
    Bongarzone, Salvatore
    Gee, Antony
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S92 - S93
  • [38] Development of [11C]/[3H-1]THK-5351-A potential novel carbon-11 tau imaging PET radioligand
    Stepanov, Vladimir
    Svedberg, Marie
    Jia, Zhisheng
    Krasikova, Raisa
    Lemoine, Laetitia
    Okamura, Nobujuki
    Furumoto, Shozo
    Mitsios, Nicholas
    Mulder, Jan
    Langstrom, Bengt
    Nordberg, Agneta
    Halldin, Christer
    NUCLEAR MEDICINE AND BIOLOGY, 2017, 46 : 50 - 53
  • [39] [11C]LBT-999, a new high selective radioligand for PET examination of the dopamine transporter.
    Saba, W
    Chalon, S
    Valette, H
    Dolle, F
    Garreau, L
    Emond, P
    Halldin, C
    Deloye, JB
    Guilloteau, D
    Bottlaender, M
    NEUROIMAGE, 2004, 22 : T160 - T160
  • [40] Development of a carbon-11 labeled thienopyrimidine based radioligand for EGFR-tyrosine-kinase-inhibitor (TKI) specific PET imaging of glioblastoma
    Guttormsen, Yngve
    Moldes-Anaya, Angel
    Fjellaksel, Richard
    Oteiza, Ana
    Martin-Armas, Montserrat
    Lindemann, Marcel
    Bihler, Julia
    Hoff, Bard Helge
    Jakobsen, Steen
    Sundby, Eirik
    Sundset, Rune
    Kranz, Mathias
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62